Literature DB >> 15451439

ERp57 is present in STAT3-DNA complexes.

Margherita Eufemi1, Sabina Coppari, Fabio Altieri, Caterina Grillo, Anna Ferraro, Carlo Turano.   

Abstract

STAT3 has been found constitutively activated in M14 melanoma cell line, as previously found in other melanoma cells. Using EMSA, DNA affinity experiments, and chromatin immunoprecipitation, STAT3 was found in M14 to bind the alpha2-macroglobulin gene enhancer in association with the protein disulfide isomerase isoform ERp57. The two proteins have also been found to be associated when bound to the SIE sequence in HepG2 cells stimulated by IL-6. In both cases an anti-ERp57 antibody hinders the binding of STAT3 to its consensus sequence on DNA, indicating that ERp57 is a necessary component of the DNA-bound STAT3 complex. Considering the functional association of the two proteins, the overexpression of ERp57 observed in a variety of transformed cells might be relevant to the oncogenic properties of STAT3.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15451439     DOI: 10.1016/j.bbrc.2004.09.009

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Roles of STAT3 in protein secretion pathways during the acute-phase response.

Authors:  Ayele-Nati N Ahyi; Lee J Quinton; Matthew R Jones; Joseph D Ferrari; Zachary A Pepper-Cunningham; Juan R Mella; Daniel G Remick; Joseph P Mizgerd
Journal:  Infect Immun       Date:  2013-03-04       Impact factor: 3.441

2.  Depletion of Dicer promotes epithelial ovarian cancer progression by elevating PDIA3 expression.

Authors:  Ying Zhu; Liqiong Cai; Jing Guo; Na Chen; Xiaoqing Yi; Yong Zhao; Jing Cai; Zehua Wang
Journal:  Tumour Biol       Date:  2016-08-05

3.  ERp57 modulates STAT3 signaling from the lumen of the endoplasmic reticulum.

Authors:  Helen Coe; Joanna Jung; Jody Groenendyk; Daniel Prins; Marek Michalak
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

4.  Tumor necrosis factor-α treatment of HepG2 cells mobilizes a cytoplasmic pool of ERp57/1,25D₃-MARRS to the nucleus.

Authors:  Brian J Grindel; Benjamin Rohe; Susan E Safford; Joseph J Bennett; Mary C Farach-Carson
Journal:  J Cell Biochem       Date:  2011-09       Impact factor: 4.429

Review 5.  Multifunctional molecule ERp57: From cancer to neurodegenerative diseases.

Authors:  Aubryanna Hettinghouse; Ronghan Liu; Chuan-Ju Liu
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

Review 6.  Contribution of chaperones to STAT pathway signaling.

Authors:  Claire E Bocchini; Moses M Kasembeli; Soung-Hun Roh; David J Tweardy
Journal:  JAKSTAT       Date:  2014-10-30

7.  Chaperone properties of pdia3 participate in rapid membrane actions of 1α,25-dihydroxyvitamin d3.

Authors:  Jiaxuan Chen; Kirill S Lobachev; Brian J Grindel; Mary C Farach-Carson; Sharon L Hyzy; Khairat B El-Baradie; Rene Olivares-Navarrete; Maryam Doroudi; Barbara D Boyan; Zvi Schwartz
Journal:  Mol Endocrinol       Date:  2013-05-09

8.  Maternal Smoking Dysregulates Protein Expression in Second Trimester Human Fetal Livers in a Sex-Specific Manner.

Authors:  Panagiotis Filis; Nalin Nagrath; Margaret Fraser; David C Hay; John P Iredale; Peter O'Shaughnessy; Paul A Fowler
Journal:  J Clin Endocrinol Metab       Date:  2015-03-24       Impact factor: 5.958

9.  Dystroglycan is associated to the disulfide isomerase ERp57.

Authors:  Francesca Sciandra; Emanuela Angelucci; Fabio Altieri; Daniela Ricci; Wolfgang Hübner; Tamara C Petrucci; Bruno Giardina; Andrea Brancaccio; Manuela Bozzi
Journal:  Exp Cell Res       Date:  2012-07-16       Impact factor: 3.905

10.  Leptin and fasting regulate rat gastric glucose-regulated protein 58.

Authors:  Susana B Bravo; Jorge E Caminos; Carmen R González; María J Vázquez; María F Garcés; Libia A Cepeda; María E R García-Rendueles; Antonio Iglesias-Gamarra; Consuelo Gómez-Díaz; Miguel Lopez; Justo P Castaño; Carlos Diéguez; Rubén Nogueiras
Journal:  Int J Pept       Date:  2011-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.